D. Arnés-García, M.L. Tornero-Divieso, A. Rosales-Castillo
{"title":"Manifestación inicial atípica de un hiperaldosteronismo primario","authors":"D. Arnés-García, M.L. Tornero-Divieso, A. Rosales-Castillo","doi":"10.1016/j.hipert.2023.02.002","DOIUrl":"10.1016/j.hipert.2023.02.002","url":null,"abstract":"<div><p>Approximately 10% of cases of arterial hypertension are due to a secondary cause, being among the most frequent primary hyperaldosteronism, characterized by hypertension, metabolic alkalosis and hypokalemia. However, on rare occasions it can present in an atypical way, in the form of muscle weakness and myalgia secondary to rhabdomyolysis due to severe hypokalemia, as in the case described.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 4","pages":"Pages 222-224"},"PeriodicalIF":0.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9446655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Araujo-Castro , E. Pascual-Corrales , P. Martín Rojas , P. Parra Ramírez
{"title":"Primary aldosteronism: Practical recommendations for treatment and follow-up","authors":"M. Araujo-Castro , E. Pascual-Corrales , P. Martín Rojas , P. Parra Ramírez","doi":"10.1016/j.hipert.2023.08.001","DOIUrl":"10.1016/j.hipert.2023.08.001","url":null,"abstract":"<div><p>Primary aldosteronism (PA) is the most common cause of secondary arterial hypertension. For unilateral cases, surgery offers the possibility of cure, with unilateral adrenalectomy being the treatment of choice, whereas bilateral forms of PA are treated mainly with mineralocorticoid receptor antagonists (MRA). The goals of treatment for PA due to either unilateral or bilateral adrenal disease include reversal of the adverse cardiovascular effects of hyperaldosteronism, normalization of serum potassium in patients with hypokalemia, and normalization of blood pressure. The Primary Aldosteronism Surgery Outcome group (PASO) published a study defining clinical and biochemical outcomes based on blood pressure and correction of hypokalemia and aldosterone to renin ratio (ARR) levels for patients undergoing total unilateral adrenalectomy for unilateral PA. In this review, we provide several practical recommendations for the medical and surgical management and follow-up of patients with PA.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 4","pages":"Pages 215-221"},"PeriodicalIF":0.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138296199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effects of cardiac rehabilitation on obese hypertensive patients: A controlled trial","authors":"H. Baykal Sahin , M. Sahin","doi":"10.1016/j.hipert.2023.05.007","DOIUrl":"10.1016/j.hipert.2023.05.007","url":null,"abstract":"<div><h3>Introduction</h3><p>The relationship between obesity and hypertension is clearly known and cardiac rehabilitation (CR) is shown as an effective treatment method in both obese and hypertensive patients. The aim of this study is to reveal the effect of CR on obese hypertensive patients by comparing them with non-obese hypertensive patients.</p></div><div><h3>Methods</h3><p>Eighty eligible, volunteer participants with hypertension (SBP ≥140<!--> <!-->mmHg and/or DBP ≥90<!--> <!-->mmHg) were enrolled in this study. The patients were divided into 2 groups according to their BMI values: obese (BMI ≥30<!--> <!-->kg/m<sup>2</sup>) hypertensive patients and non-obese (BMI <30<!--> <!-->kg/m<sup>2</sup><span>) hypertensive patients. The CR program, in which aerobic exercise training was the main part, was performed on the patients. At the end of the 10-week CR program, the resting SBP and DBP values were measured.</span></p></div><div><h3>Results</h3><p>A total of 74 patients (37 obese and 37 non-obese) completed the study. After CR significant improvements were achieved in all evaluated parameters compared to pre-CR values. When the amounts of changes before and after CR were compared, the decrease in SBP was found to be significantly higher in obese patients compared to non-obese patients (<em>p</em> <!-->=<!--> <!-->.003). Higher BMI was associated with more reduction in SBP (<em>r</em> <!-->=<!--> <!-->0.287, <em>p</em> <!-->=<!--> <!-->0.013).</p></div><div><h3>Conclusions</h3><p>Exercise-based CR effectively reduced SBP in obese and non-obese hypertensive patients. However, it was more effective in obese patients compared to non-obese patients.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 4","pages":"Pages 197-204"},"PeriodicalIF":0.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138048144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G. Oscullo , J.D. Gómez-Olivas , M.Á. Martínez-García
{"title":"Obstructive sleep apnoea: A hidden cause of refractory hypertension?","authors":"G. Oscullo , J.D. Gómez-Olivas , M.Á. Martínez-García","doi":"10.1016/j.hipert.2023.09.001","DOIUrl":"10.1016/j.hipert.2023.09.001","url":null,"abstract":"","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 4","pages":"Pages 171-173"},"PeriodicalIF":0.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138291926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Minoxidil oral sin relación con la hipertensión arterial: incidencias por su uso creciente","authors":"C. Albaladejo Blanco , R. Alonso Martínez","doi":"10.1016/j.hipert.2023.11.002","DOIUrl":"10.1016/j.hipert.2023.11.002","url":null,"abstract":"","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 4","pages":"Pages 228-230"},"PeriodicalIF":0.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138296188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Successful treatment of multidrug-resistant hypertension with catheter-based renal denervation in a patient with a renal artery stent","authors":"C. Yılmaz , B. Güvendi Şengör , R. Zehir","doi":"10.1016/j.hipert.2023.04.004","DOIUrl":"10.1016/j.hipert.2023.04.004","url":null,"abstract":"<div><p><span>Renal artery<span> stenting (RAS) and its effectiveness in the treatment<span> of atherosclerotic renal artery disease are controversial.</span></span></span><span><sup>1</sup></span><span> Catheter-based renal denervation (RDN) has been shown to reduce blood pressure in the treatment of multidrug-resistant hypertension.</span><span><sup>2</sup></span><span> In this case, we presented the successful regulation of multidrug resistant hypertension after renal denervation in a patient with renal artery stent.</span></p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 4","pages":"Pages 225-227"},"PeriodicalIF":0.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9844368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Síntomas del tracto urinario inferior en pacientes con hipertensión arterial. Riesgo cardiovascular e impacto en su calidad de vida","authors":"M. Diosdado-Figueiredo","doi":"10.1016/j.hipert.2023.05.008","DOIUrl":"10.1016/j.hipert.2023.05.008","url":null,"abstract":"<div><h3>Objetives</h3><p>To determine the prevalence of erectile lower urinary tract symptoms in hypertensive patients, cardiovascular risk and the impact on quality of life.</p></div><div><h3>Material and methods</h3><p>Setting: Health Center (Vilagarcia, Pontevedra).</p><p>Period: April 2015-June 2017.</p><p>Inclusion criteria: Hypertensive patient with informed consent.</p></div><div><h3>Measurements</h3><p>sociodemographic variables, toxic habits, comorbidity, blood pressure, cardiovascular risk, analytical and examination parameters. Questionaries: International Prostate Symptom Scale (IPSS), International Index of Erectile Function (IIEF-15) and quality of life in arterial hypertension (MINICHAL).</p><p>Sample size: n<!--> <!-->=<!--> <!-->262 (± 6% accuracy, 95% confidence).</p><p>Statistical analysis: Bivariate and multivariate statistical analysis.</p><p>Informed consent and ethics committee approval were obtained (2024/237)</p></div><div><h3>Results</h3><p>The mean age was 65.84 (12.70), and mean hypertension duration of 13.25 (9.84) years. 76.7% reported lower tract urinary symptoms, 91.6% being mild. The bivariate analysis showed an association with the variables: age, educational level, profession, work activity, tobacco, benign prostatic hypertrophy, years of diagnosis, concomitant medication, Framingham-Wilson score, electrocardiogram, glycated hemoglobin, glomerular filtration (Crockroft-Gault), LDL-cholesterol, somatic manifestations (MINICHAL), erectile dysfunction. The multivariate analysis showed increased risk with:abdominal obesity, pathological electrocardiogram, high risk of Framingham-Wilson score, erectile dysfunction, use of hypouricemics agents and decreased with not smoking and use diuretics.</p></div><div><h3>Conclusions</h3><p>Three quarters of hypertensive men presented lower urinary tract symptoms, increasing the risk of cardiovascular disease early according to the Framingham-Wilson score. Other predictive factors were: abdominal obesity, tobacco, pathological electrocardiogram, high Framingham-Wilson score, erectile dysfunction, use of hypouricemics agents.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 4","pages":"Pages 205-214"},"PeriodicalIF":0.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138048143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}